ABSTRACT. Stem cell based cell therapies offer significant potential for the field of regenerative medicine. Human amniotic fluid stem cells (hAFSCs) are an attractive source for lineage-specific differentiated stem cell therapy since they have properties that are able to differentiate into cells representing all three germ layers. To better understand the fate and location of implanted hAFSCs, a means to monitor cells in living subjects is essential. Here, we showed that differentiated cells, such as neurogenic, endothelial, and myogenic cells, derived from hAFSCs can be effectively labeled by the FITC-incorporated silica-coated nanoparticles, MNPs@SiO2 (FITC), although the labeling efficacy and cytotoxicity were distinct depending on the differentiated cell type. In addition, we observed that MNPs@SiO2-labeled cells provided sufficient signals for detection by optical and confocal microscope imaging when transplanted into the mice. These results suggest that the fluorescent dye incorporated MNPs@SiO2 are a useful tool for the cell labeling and in vivo tracking of differentiated cells derived from hAFSCs.
Stem cells hold great promise for use in tissue repair and regeneration, and there has been continuing interest in both the biology and potential therapeutic applications of these cells. Preclinical in vivo studies have shown a generally positive effect of infusing stem cells for the regeneration of various tissues [3, 5, 14] . However, the safety of naïve stem cell therapy in human patients remains controversial since the possibility of unwanted proliferation or differentiation of the transplanted stem cells cannot be excluded. One approach to overcome this problem for stem cell therapy is to initiate lineage-specific differentiation in vitro and then allow cells to complete their development and acquisition of specialized functions in vivo. Human amniotic fluid stem cells (hAFSCs) have properties that are able to differentiate into cells representing all three germ layers given the proper environment. hAFSCs are able to differentiate along neurogenic, myogenic, endothelial, adipogenic, and osteogenic pathways [4] . In addition, hAFSCs can be obtained noninvasively, induce immune tolerance, have a high proliferation rate, and share many properties with embryonic stem cell [4] . Thus, hAFSCs are an attractive source for a variety of therapeutic applications in numerous diseases.
While preclinical results of stem cells including hAFSCs have been very promising, few studies have been translated to successful treatment in humans. This is likely in part due to the lack of a comprehensive understanding of the fate and distribution of the infused cells [16] . Therefore, it is critical to use a non-invasive labeling agent to understand the fate, location, and function of the implanted stem cells [7] . In the past, histopathological methods were used to assess engraftment, migration, and differentiation of exogenous transplanted stem cells. For example, stem cells were transfected with green fluorescent protein (GFP) gene by using viral vectors; nuclei of stem cells were stained with fluorescence dye using DAPI and Hoechst, and the DNA of stem cells was labeled with 5-bromodeoxyuridine (BrdU). However, these approaches have only been used to obtain information on the fate of the implanted cells at the time of animal euthanization or through biopsy or surgery. In addition, fluorescent materials have photobleaching problems [6] and are not appropriate for long-term monitoring of infused stem cells.
Recent advances in nanotechnology for stem cell tracking have been developed to overcome the disadvantage of traditional methods. For example, a magnetic resonance imaging (MRI) contrast agent that consists of superparamagnetic iron oxide nanoparticles (SPION) and quantum dots (QDs) that possess good physical and photo stability, have been used in stem cell tracking [1, 2, 10, 11] . However, these materials also have some problems. For example QDs have been shown to have cellular cytotoxicity [9] . In addition, the sensitivity of SPION is in the micromolar range; as such, they may not be sensitive enough to detect low signal levels [8] .
To overcome these problems, fluorescent dye incorporated silica-coated magnetic nanoparticles (MNPs) as coreshell structures, referred to herein as MNPs@SiO2, were recently developed [18] . These nanoparticles can be used in diverse visualizing systems, such as fluorescent microscopy, optical imaging systems, and MRI [13] . MNPs@SiO2 very effectively labeled diverse cells including stem cells and are not cytotoxic to the cells [13, 17] .
Based on these concepts and findings, this study was designed to determine whether differentiated cells, such as neurons, endothelial cells, and myogenic cells, derived from hAFSCs were effectively labeled by silica-coated nanoparticles, and if so, whether the labeled cells produced sufficient signals detectable in live animals for in vivo tracking.
MATERIALS AND METHODS

Isolation and culture of hAFSCs:
Ten-milliliter samples of amniotic fluid were obtained with informed consent from 4 patients undergoing amniocentesis for prenatal diagnosis at 15-19 weeks of pregnancy. The amniotic fluid was centrifuged and the supernatants were discarded. The cell containing pellets were resuspended with Chang medium [α -MEM, 15% embryonic stem cell-fetal bovine serum (Gibco-Invitrogen, Grand island, NY, U.S.A.) with 18% Chang B and 2% Chang C (Irvine Scientific, Irvine, CA, U.S.A.)] and placed in petri dishes. Non-adherent cells were discarded after 1 week. Adherent cells were passaged for expansion when they achieved 80% confluence, and the culture medium was replaced every 3 days. At passage 3, the cultured cells were characterized with Fluorescent Activated Cell Sorting (FACS) using mesenchymal (SSEA4, CD44, CD73, CD 90 and CD105) and hematopoietic (CD45) stem cell markers (BD Biosciences, San Jose, CA, U.S.A.). To obtain a homogenous stem cell population, cells were sorted twice using the c-kit antibody (SantaCruz Biotechnology, Santa Cruz, CA, U.S.A.) with the magnetic activated cell sorting system (MACS, Miltenyi Biotec, Germany). In addition, we were able to obtain the highest c-kit (+) population and these cells were used for subsequent studies. The Ethics Committee of Kyungpook National University School of Medicine approved this study.
Neurogenic differentiation of hAFSCs in vitro:
Cells were seeded at a density of 3,000 cells/cm 2 on cell culture plates and cultured in DMEM low-glucose medium, antibiotics, supplemented with 2% DMSO, 200 μM butylated hydroxyanisole (BHA, Sigma-Aldrich, Seoul, South Korea), and nerve growth factor (NGF, 25 ng/ml). After 2 days the cells were returned to Chang medium without DMSO and BHA but still containing NGF. Fresh NGF was added at intervals of 2 days [4] .
Myogenic differentiation of hAFSCs in vitro:
Cells were seeded at a density of 3,000 cells/cm 2 on plastic plates precoated with Matrigel (Collaborative Biomedical Products; incubation for 1 hr at 37°C at 1 mg/ml in DMEM) in DMEM low-glucose formulation containing 10% horse serum (Gibco), 0.5% chick embryo extract (Gibco), and antibiotics. Twenty-four hours after seeding, 3 μM 5-aza-2'-deoxycytidine (5-azaC; Sigma-Aldrich) and TGF-β were added to the culture medium for 24 hr and the cells were cultured up to 14 days [4] .
Endogenic differentiation of hAFSCs in vitro: Cells were seeded at 3,000 cells/cm 2 on plastic plates precoated with gelatin and maintained in culture for 1 month in endothelial cell medium-2 (EG-M™-2, Clonetics; Cambrex Bioproducts) supplemented with 10% FBS, and antibiotics. Recombinant human bFGF (StemCell Technologies, Vancouver, BC, Canada) was added at intervals of 2 days at 2 ng/ml [4] .
Protocol of cell labeling with nanoparticles:
To analyze the labeling of MNPs@SiO2 (FITC) (Biterials, Korea), cells were treated with 0.01, 0.05, 0.1 or 0.2 mg/ml of MNPs@ SiO2 (FITC). Parallel wells received the vehicle, which was sterile water of equal volume without MNPs@SiO2 (FITC). For fluorescence analysis, cell-discs were permeabilized and transferred to slides, fixed, coverslipped, and mounted with VECTASHIELD mounting medium with DAPI (Vector Laboratories, Burlingame, CA, U.S.A.) at different time points. Cells were examined under a fluorescence microscope (Olympus BX51, Tokyo, Japan) and confocal microscope (Olympus FluoView TM FV1000, Tokyo, Japan) to detect the localization of nanoparticles.
Cell proliferation and viability: The effect of MNPs@ SiO2 (FITC) on the growth of the differentiated cells derived from hAFSCs was assessed using the WST-1 assay (Roche). Briefly, 1 × 10 3 cells/well were seeded into sterile 96-well plates. After the differentiation procedures, MNPs@ SiO2 (FITC) were added to the culture medium over a final concentration range of 0.01-2.0 mg/ml, and the cells were incubated for an additional 24-72 hr. WST-1 solution was then added to each well, and the cells were further incubated. After 4 hr, the absorbance was measured with a plate reader at 440 nm. Cells incubated without nanoparticles were used as a control.
Flow cytometric analysis: To determine the cellular uptake of the nanoparticles, we analyzed the FITC dye signal from the MNPs@SiO2 (FITC) using a FACS Calibur and FACSDiva software (BD Biosciences). Briefly, 1 × 10 5 cells were seeded into 6 cm culture dish. After the differentiation procedures, MNPs@SiO2 (FITC) were added to the culture medium and the cells were incubated for an additional 24 hr. The MNPs@SiO2 (FITC)-labeled cells were washed and harvested. After centrifugation, the labeled cells were washed twice with PBS and analyzed.
Generation of the incompetent urethral sphincter model: Female nude mice weighing 20-25 g were obtained from Jackson Laboratories (Bar Harbor, ME, U.S.A.). Animals were prepared for aseptic surgery under general anesthesia (isoflurane). A lower midline abdominal incision was made. The bladder and urethra were exposed. The pudendal nerve on each side was identified and transected with microsurgical scissors under microscopic magnification. Laparotomy was closed in layers with absorbable 4-0 Vicryl sutures. All procedures were performed in accordance with an animal protocol approved by the Kyungpook National University Institutional Animal Care and Use Committee (IACUC).
Transplantation of MNPs@SiO2 (NIR797)-labeled cells and imaging:
After the generation of the incompetent urethral sphincter model, the urethra was slightly retracted and MNPs@SiO2 (NIR797)-labeled cells were delivered to the area of the externalsphincter at 3 and 9 o'clock using a 26G Hamilton microsyringe (Hamilton Co., Reno, NV, U.S.A.). The depth of the injections was determined by an experienced operator. Each injection consisted of 0.5 × 10 6 cells in 5 µl of Plasma-Lyte. Optical images were obtained for 14 days using Optix exPlore (ART, Montreal, Canada) with the filters set for NIR797. Images were analyzed with eXplore Optix OptiView software.
Immunohistochemistry: Animals were sacrificed at 2 weeks after cell transplantation, and the bladder-urethra complex was then removed en bloc. Tissues were fixed in 10% buffered formalin, processed and cut in 4 to 6 µm sections for immunohistochemistry. The presence of FITC-labeled injected cells was analyzed using confocal microscopy.
RESULTS
Determining the optimal conditions for labeling of differentiated cells derived from hAFSCs:
In the experiment to determine optimal concentration and time for cell labeling that was sufficient for in vivo tracking, we observed the doseand time-dependent labeling efficiency of the cells (data not shown). The differentiated cells derived from hAFSCs were effectively labeled with MNPs@SiO2 (FITC) at a concentration of 0.2 mg/ml for 24 hr (Fig. 1A) . The fluorescent signal was distributed in the cytoplasm, and not in the nucleus (Fig. 1A) . To examine the labeling efficiency, we used flow cytometric analysis. Although, the cells that displayed the FITC signal were different depending on the differentiated cell type, the FITC-labeled cells were clearly observed (Fig.  1B) . In the nanoparticle-labeled neurogenic, endothelial, and myogenic differentiated cells, 18.3, 97.7, and 47.3% of cells, respectively, expressed the FITC signals.
Cytotoxic evaluation of MNPs@SiO2 (FITC) after exposure to differentiated cells derived from hAFSCs:
In the experiments for cell cytotoxicity, there were no differences in cell viability in neurogenic and myogenic differentiated hAFSCs for various concentrations and times ( Fig. 2A and  2C) . However, the endothelial differentiated cells treated with MNPs@SiO2 (FITC) showed decreased cell viability in a concentration-dependent manner (Fig. 2B ). There were no differences in cell viability for the incubation time of MNPs@SiO2 (FITC).
In vivo tracking of MNPs@SiO2 (NIR797) labeled cells in mice:
In vivo fluorescence imaging was taken at 1, 7, 10, and 14 days (Fig. 3A) . The composite image clearly showed the presence of cells labeled with MNPs@SiO2 (NIR797) at the injection sites (Fig. 3A) . The signal intensity decreased gradually till 10 days after cell transplantation and disappeared at 14 days (data not shown). To confirm the presence of labeled cells in the animals, we used MNPs@SiO2 (FITC) labeled cells. At 14 days after cell transplantation, we sacrificed the animals, harvested their bladder-urethra complex tissues, and then examined the tissues to detect the presence of nanoparticle-positive differentiated cells. As shown in Fig. 3B , the fluorescence from nanoparticle-labeled cells was clearly visible and plentiful enough to be detected by microscopy.
DISCUSSION
The major findings of this study are that neurogenic, endothelial, and myogenic differentiated cells derived from hAFSCs can be labeled by fluorescent or near infrared dye incorporated MNPs@SiO2. We demonstrated that MNPs@ SiO2 are biocompatible materials for in vivo monitoring of differentiated cells derived from hAFSCs. They are easily visible by optical imaging without invasive and laborious methods. After transplantation into the mice, the labeled cells provided sufficient signals for in vivo tracking by optical imaging. In addition, the differentiated cells labeled with fluorescent dye incorporated MNPs@SiO2 showed strong signals that were plentiful enough to detect by fluorescent microscopy in vivo and in vitro.
Our study showed the dose and time-dependent uptake of MNPs@SiO2 (FITC) in neurogenic, endothelial, and myogenic differentiated cells derived from hAFSCs, although the efficiency of labeling was different depending on the cellular types (Fig. 1) . The discrepancy in uptake of MNPs@SiO2 may be due to differences in endocytosis ability among the differentiated cells since the internalization of MNPs@SiO2 (FITC) is mediated by endocytosis through the endosome-lysosome pathway [18] . Microscopic observation of MNPs@SiO2 (FITC)-labeled cells revealed that the fluorescence signals were located in the cytoplasm of labeled cells (Fig. 1A ), in line with previous studies on mesenchymal stem cells [13] .
Cytotoxic effects of MNPs@SiO2 (FITC) were not found in neurogenic and myogenic differentiated cells. However, we found a dose-dependent decrease in cell viability on the endothelial differentiated cells. A time-dependent cytotoxic effect was not detected up to 72 hr. Park et al. reported that MNPs@SiO2 were not cytotoxic in human mesenchymal stem cells [13] . Our unpublished data also showed MNPs@ SiO2 was not cytotoxic in hAFSCs. In this study, however, MNPs@SiO2 exhibited cytotoxicity in the endothelial differentiated cells derived from hAFSCs. Actually, recent observations indicated that SiO2 nanoparticles cause cytotoxicity in some cells [12, 15] . Exposure to 20 or 50 nm SiO2 nanoparticles decreased cell viability of human embryonic kidney (HEK293) cells in a dose-dependent manner [15] . Also, exposure to silica nanoparticles caused cytotoxic damage and a decrease in cell survival in the human endothelial cells in a dose-and size-dependent manner [12] . Therefore, one of the possible explanations for the cytotoxic effect of MNPs@SiO2 in our results could be that we induced the hAFSCs to undergo endothelial lineage. Taken together, our results suggest that cytotoxic effect of MNPs@SiO2 was different depending on the cellular type.
Finally, we performed in vivo optical imaging to confirm that the labeled cells had sufficient signal strength after infusion into mice. The optical images clearly showed the presence of the cells labeled with MNPs@SiO2 (NIR797) at the injection sites until 10 days (Fig. 3A) . This would be applicable to a wide range of cell-based research studies. We also observed fluorescent signals of MNPs@SiO2-labeled cells in the bladder-urethra complex tissues using confocal microscopy at 14 days after cell transplantation (Fig.  3B) . The possible explanation for the different persistence between the optical signals and confocal images is possibly due to the dilution effect after cell division or cell death since optical imaging equipment requires stronger fluorescence signals than that of confocal microscopy. In summary, this study revealed that fluorescent dye incorporated MNPs@SiO2 can be taken up by neurogenic, endothelial, and myogenic differentiated cells derived from hAFSCs. Moreover, MNPs@SiO2-labeled cells can be easily detected and tracked using in vivo optical imaging and fluorescent microscope. These results may be beneficial to stem cell-based therapies for clinical implementation. Even though MNPs@SiO2 are effective nanoparticles for cellular labeling and cell tracking, some toxicity and efficiency issues need to be resolved before use in clinical applications. In addition, the MNPs@SiO2 concentration should be carefully taken into account when using MNPs@SiO2-based cell tracking techniques in clinical practice. Further studies will focus on reducing the cytotoxicity and increasing the labeling efficacy of the MNPs@SiO2 in differentiated cells derived from AFSCs. 
